Serum Institute of India to Produce up to 100 Million COVID-19 Vaccine Doses for India and…

SERUM INSTITUTE OF INDIA TO PRODUCE UP TO 100 MILLION COVID-19 VACCINE DOSES FOR INDIA AND LOW- AND MIDDLE-INCOME COUNTRIES AS EARLY AS 2021

Press Release by Adar Poonawalla, CEO and Owner, Serum Institute of India
Press Release by Adar Poonawalla, CEO and Owner, Serum Institute of India

• New landmark collaboration between the Serum Institute of India (SII), Gavi, and Bill & Melinda Gates Foundation

• The Bill & Melinda Gates Foundation, via its Strategic Investment Fund, will provide at- risk funding of US$150 million to Gavi, which will be used to support the SII to manufacture the potential vaccine candidates

• Vaccines will be priced at maximum US$ 3 per dose and made available to the 92 countries included in Gavi’s COVAX Advance Market Commitment (AMC)

Serum Institute of India (SII), the world’s largest vaccine manufacture

Serum Institute of India (SII), the world’s largest vaccine manufacturer by volume, has entered into a new landmark partnership with Gavi, The Vaccine Alliance and the Bill & Melinda Gates Foundation, to accelerate the manufacture and delivery of up to 100 million doses of COVID-19 vaccines for India and low- and middle-income countries (LMICs).

Adar Poonawalla shared this news via his tweet:

The Bill & Melinda Gates Foundation, via its Strategic Investment Fund, will provide at-risk funding of US$150 million to Gavi, which will be used to support the Serum Institute of India to manufacture potential vaccine candidates, and for future procurement of vaccines for low- and middle-income countries via Gavi’s COVAX AMC.

The press release is available as an official announcement by Serum Institute of India on their Facebook page.

Also Read – Business Challenges and Opportunities in COVID-19

Sharer this to:

Vanesh

Software Professional, Blogger. He writes about Blogging Tips, SEO Tips, Motivational REAL Stories, Startup Stories, Website Development, Programming, etc.

Leave a Reply

Your email address will not be published. Required fields are marked *